Andrew Saunders
Director Técnico/Científico/I+D en CellCentric Ltd. .
Cargos activos de Andrew Saunders
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Director Técnico/Científico/I+D | - | - |
Historial de carrera de Andrew Saunders
Antiguos cargos conocidos de Andrew Saunders.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| REDX PHARMA PLC | Director Técnico/Científico/I+D | 22/01/2018 | 01/03/2021 |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Director Técnico/Científico/I+D | 01/05/2005 | 09/04/2007 |
| Linden Oncology Ltd. | Director Ejecutivo | - | - |
| LYTIX BIOPHARMA | Director Técnico/Científico/I+D | 19/01/2015 | - |
Formación de Andrew Saunders.
| Trinity College Dublin | Doctorate Degree |
Estadísticas
Internacional
| Reino Unido | 4 |
| Estados Unidos | 2 |
| Noruega | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 4 |
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Health Services | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| REDX PHARMA PLC | Health Technology |
| Empresas privadas | 3 |
|---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Linden Oncology Ltd. |
- Bolsa de valores
- Insiders
- Andrew Saunders
- Experiencia
